Health Canada approves remdesivir to treat severe COVID-19 symptoms

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States in this March 2020 photo provided by Gilead Sciences. Health Canada has approved the use of remdesivir to treat patients with severe symptoms of COVID-19. The federal agency says the antiviral drug may be used to treat patients who have pneumonia and require extra oxygen to help them breathe. THE CANADIAN PRESS/HO - AP, Gilead Sciences